img
img
Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients   
Yazarlar (6)
Hamiyet Altuntaş
Türkiye
Fahri Bayram
Türkiye
Dr. Öğr. Üyesi Ayşe Nur COŞKUN DEMİRKALP Dr. Öğr. Üyesi Ayşe Nur COŞKUN DEMİRKALP
Kırşehir Ahi Evran Üniversitesi, Türkiye
Osman Başpınar
Türkiye
Derya Koçer
Türkiye
Peter P Toth
Devamını Göster
Özet
Statins are a group of cholesterol lowering drugs and frequently used in the therapy of dyslipidemia. Our knowledge of the impact of statin therapy on DNA damage is as yet rudimentary. In this study, we aimed to assess the possible (1) genotoxic, cytostatic, and cytotoxic effects of statins in peripheral blood lymphocytes by using the cytokinesis-block micronucleus cytome (CBMN-cyt) assay, and (2) oxidative DNA damage by measuring plasma 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels in response to statin therapy. Thirty patients with dyslipidemia who had no chronic diseases and did not use any medicines that interfere lipid values and twenty control subjects were included in the study. Statin therapy was initiated at risk-stratified doses. Blood samples were taken before and after treatment with statins and from control subjects, and CBMN-cyt assay parameters and 8-OHdG levels were evaluated. The …
Anahtar Kelimeler
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Experimental Biology and Medicine
Dergi ISSN 1535-3702 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q2
Makale Dili İngilizce
Basım Tarihi 08-2019
Cilt No 244
Sayı 13
Sayfalar 1089 / 1095
Doi Numarası 10.1177/1535370219871895
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 17
Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients

Paylaş